Dyne Therapeutics gets BTD for DYNE-101 in Myotoni...
Category : Clinical Trial Update 19 June 2025Overview Dyne Therapeutics has announced that the U.S. Food and Drug Administration (FDA) has gra...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
AbbVie: Atogepant Outperforms Topiramate in Phase...
Category : Clinical Trial Update 19 June 2025Overview AbbVie (NYSE: ABBV) today announced positive topline results from its Phase 3 TEMPLE mul...
EVEREST phase 4 study of Dupixent shows positive r...
Category : Clinical Trial Update 18 June 2025Overview Sanofi and Regeneron Pharmaceuticals, Inc. presented positive results from the EVERES...
Emory & Micron Start First Human Trial of Rotaviru...
Category : Clinical Trial Update 18 June 2025Overview Emory University and Micron Biomedical today announced the first clinical trial of a nov...
Ascletis Doses First Participants in U.S. Phase I...
Category : Clinical Trial Update 18 June 2025Overview Ascletis Pharma Inc. (HKEX: 1672, ""Ascletis"") announces that the f...
Latest Newsletter Post
-
AbbVie: Atogepant Outperforms Topir..
19 June 2025
-
Dyne Therapeutics gets BTD for DYNE..
19 June 2025
-
Innovent completes first patient do..
18 June 2025
-
Skyhawk Therapeutics Announces SKY-..
18 June 2025
-
Ascletis Doses First Participants i..
18 June 2025
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com